Daniil L. Stroyakovskiy - Department of Chemotherapy, Moscow City Oncology Hospital №62

基本信息

浏览量：145

职业迁徙

个人简介

70 publications in national scientific editions
ICH GCP course X7 Research Certificate # 18974, Russia, of January 2021

研究兴趣

论文共 159 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Efficacy and Safety of Trastuzumab Deruxtecan in Patients with HER2-Expressing Solid Tumors: Primary Results from the DESTINY-PanTumor02 Phase II Trial

Funda Meric-Bernstam,Vicky Makker,Ana Oaknin,Do-Youn Oh,Susana Banerjee,Antonio Gonzalez-Martin,Kyung Hae Jung,Iwona Lugowska,Luis Manso,Aranzazu Manzano,Bohuslav Melichar,Salvatore Siena,Daniil Stroyakovskiy,Anitra Fielding, Yan Ma,Soham Puvvada,Norah Shire,Jung-Yun Lee

JOURNAL OF CLINICAL ONCOLOGYno. 1 (2024): 47-+

引用0浏览0WOS引用

LBA55 Mechanisms of Acquired Resistance to First-Line Amivantamab Plus Lazertinib Versus Osimertinib in Patients with EGFR-mutant Advanced Non-Small Cell Lung Cancer: an Early Analysis from the Phase III MARIPOSA Study

B. Besse,S-H. Lee, S. Lu,D. Stroyakovskiy, O. Yazici,J.R. Rodriguez Cid, H. Hayashi, D. Nguyen,J.C-H. Yang, M. Gottfried, A.C. Gelatti, S. Owen,S-H.I. Ou, M. Ennis, S. Sethi,J.M. Bauml, J. Zhang,J.C. Curtin, B.C. Cho

Annals of Oncology (2024)

引用0浏览0引用

Efficacy and Safety of Trastuzumab Deruxtecan (T-Dxd) in Patients (pts) with HER2-expressing Solid Tumors: Results from the Bladder Cohort of the DESTINY-PanTumor02 (DP-02) Study

Piotr Jan Wysocki, Kyung Hae Jung, Do-Youn Oh,Deborah Blythe Doroshow,Elena Artamonova, Lemonitsa Mammatas, Po-Jung Su,Vladimir Moiseyenko, Konstantin Penkov,Daniil Stroyakovskiy, Jorge Bartolome,Salvatore Siena, Anitra Fielding, Lindsey Jung,Flavia Michelini,Soham D. Puvvada,Vicky Makker

Journal of Clinical Oncologyno. 16_suppl (2024): 4565-4565

引用0浏览0引用

Prolgolimab with Chemotherapy As First-Line Treatment for Advanced Non-Squamous Non-Small-Cell Lung Cancer

Konstantin Laktionov,Alexey Smolin,Daniil Stroyakovskiy,Vladimir Moiseenko,Mikhail Dvorkin,Timur Andabekov,Ying Cheng,Baogang Liu,Vadim Kozlov, Sveltana Odintsova, Sergey Dvoretsky,Anastasia Mochalova, Michal Urda,Tienan Yi,Xingya Li,URBÁN László,Veronika Müller,Krisztina Bogos,Natalia Fadeeva, Gaziyavdibir Musaev, Qun Liu, Dmitriy Kirtbaya,Jianhua Shi,Oleg Gladkov, Mehti Narimanov,Tatiana Semiglazova, Alfia Khasanova,Jozef Chovanec,Igor Andrašina, Alexandea Szabová, Oľga Rosinská, Dagmar Sudeková,Zsolt Pápai-Székely,Fengming Ran,Meili Sun, Ou Jiang, Rixin Chen, Enfeng Zhao,Chunling Liu,Wei Tan, Albert Pirmagomedov,Elena Poddubskaya,Nikolay Kislov, Irina Shumskaya,Irina Sorokina,Arina Zinkina-Orikhan, Yulia Linkova,Sergey Fogt, Daria Liaptseva, Anna Siliutina, Olga Basova,Fedor Kryukov

crossref（2024）

引用0浏览0引用

DESTINY-Breast07: Dose-expansion Interim Analysis of T-DXd Monotherapy and T-DXd + Pertuzumab in Patients with Previously Untreated HER2+ Mbc

Fabrice Andre,Erika P. Hamilton,Sherene Loi,Carey K. Anders,Peter Schmid,Daniil Stroyakovskiy,Rafael Villanueva,Jose Luiz Pedrini,Dinesh Chandra Doval,Bogdan Zurawski,Shin-Cheh Chen,Sarice Renee Boston,Adam Konpa, Barbara Pierotti,Giulia Fabbri,Komal L. Jhaveri

Journal of Clinical Oncologyno. 16_suppl (2024): 1009-1009

引用0浏览0引用

Trastuzumab Deruxtecan (T-Dxd) in Patients (pts) with HER2-expressing Head and Neck Tumors: Outcomes from DESTINY-PanTumor02 (DP-02)

Funda Meric-Bernstam,Seung Tae Kim,Napa Parinyanitikul,Alberto Moreno, Chia-Chi Lin, Dmitry Gornastolev,Jarin Chindaprasirt,Iwona A. Lugowska,Daniil Stroyakovskiy,Jacek Jassem,Michelle L. Harrison,Vikas S. Ostwal,Flavia Michelini, Lindsey Jung,Nataliya Kuptsova-Clarkson,Soham D. Puvvada, Hui Kong Gan

Journal of Clinical Oncologyno. 16_suppl (2024): 6037-6037

引用0浏览0引用

BRCA-associated Ovarian Cancer in the Russian Patient Population. Analysis of the Non-Interventional Study Ovatar

Tatiana Tikhomirova,Alexandra Tyulyandina, А. А. Rumyantsev,E. R. Israelyan,Т. В. Кекеева,Olga Vedrova, М. Л. Филипенко, L. N. Lyubchenko,Ирина Демидова, Evgeny N. Imyanitov, Сергей Юрьевич Андреев,С. В. Хохлова,В. В. Саевец,Galina Statsenko,Л. А. Коломиец, S. Tkachenko,Irina Koroleva,Alla Lisyanskaya, Oksana Bakashvili,Л. И. Крикунова, E. P. Solovieva,Д. М. Пономаренко,Liubov Yu Vladimirova,С. Э. Красильников,Vadim Shirinkin,Dina Sakaeva, Е. А. Rumyantseva, S. A. Emeliyanov,Daniil Stroyakovskiy, Е. Г. Новикова, Е А Ронина,Vladimir Vladimirov,Olga Novikova, Lyubov Zagumennova, В. В. Горобцова, Е. В. Черепанова, E. N. Pashkova,Vladimir Moiseyenko, Ф. Г. Иванова, Dmitry Udovitsa,В. Карасева,Sergei Tjulandin

Zlokačestvennye opuholino. 4 (2024): 46-59

引用0浏览0引用

Trastuzumab Deruxtecan (T-Dxd) in Patients (pts) with HER2-expressing Biliary Tract Cancer (BTC) and Pancreatic Cancer (PC): Outcomes from DESTINY-PanTumor02 (DP-02)

Do-Youn Oh,Iwona A. Lugowska,Daniil Stroyakovskiy,Kyung Hae Jung,Olivier Dumas,Konstantin Penkov,Arunee Dechaphunkul,Ana Oaknin,Seung Tae Kim,Naureen Starling,Busyamas Chewaskulyong,Chanchai Charonpongsuntorn,Deborah Blythe Doroshow,Sheng-Yen Hsiao,Yi-Ping Hung, Lindsey Jung,Nataliya Kuptsova-Clarkson,Flavia Michelini,Soham D. Puvvada, Funda Meric-Bernstam

JOURNAL OF CLINICAL ONCOLOGYno. 16 (2024)

引用0浏览0引用

114P Fixed-dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection (PH FDC SC) Plus Chemotherapy in HER2-positive Early Breast Cancer (EBC): Long-term Efficacy and Safety Analysis of the Randomised, Open-Label, Multicentre Phase III (neo)adjuvant FeDeriCa Study

C. Jackisch,S-A. Im,A. Mattar, R. Colomer Bosch,D. Stroyakovskiy,Z. Nowecki,M. De Laurentiis,J-Y. Pierga,K.H. Jung, C. Schem, S.H. Heeson, V. Craine, B. Wang,E. Restuccia,A.R. Tan

ESMO Open (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn